Harding Loevner LP Novartis Ag Transaction History
Harding Loevner LP
- $17.1 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,428Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.22 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.2 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$810 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$699 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$577 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $215B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...